Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-3%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$44.4B
AUM Growth
+$1.2B
(+2.8%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281
Top Buys
| 1 |
Broadcom
AVGO
|
$410M |
| 2 |
Salesforce
CRM
|
$397M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$351M |
| 4 |
Boston Scientific
BSX
|
$348M |
| 5 |
Intuitive Surgical
ISRG
|
$286M |
Top Sells
| 1 |
Visa
V
|
$575M |
| 2 |
Eli Lilly
LLY
|
$532M |
| 3 |
Meta Platforms (Facebook)
META
|
$386M |
| 4 |
Progressive
PGR
|
$357M |
| 5 |
Lam Research
LRCX
|
$271M |
Sector Composition
| 1 | Technology | 25.88% |
| 2 | Healthcare | 15.37% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Harvard Bioscience
HBIO
$21.3M
| $76.7K | ﹤0.01% |
135,556
+107,000
| +375% | +$60.6K |
|
2277
Immunome
IMNM
$916M
| $76.7K | ﹤0.01% |
11,400
-36,800
| -76% | -$248K |
|
2278
Humacyte
HUMA
$226M
| $76K | ﹤0.01% |
44,600
-102,500
| -70% | -$175K |
|
2279
Werewolf Therapeutics
HOWL
$61.7M
| $74.9K | ﹤0.01% |
77,000
-62,100
| -45% | -$60.4K |
|
2280
Personalis
PSNL
$465M
| $73K | ﹤0.01% |
20,800
-13,500
| -39% | -$47.4K |
|
|
WHWK
2281
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
| $72.9K | ﹤0.01% |
40,969
-20,717
| -34% | -$36.9K |
|
2282
Cardlytics
CDLX
$49.6M
| $71.2K | ﹤0.01% |
39,100
+2,200
| +6% | +$4K |
|
2283
TrueCar
TRUE
$191M
| $70K | ﹤0.01% |
44,300
+11,300
| +34% | +$17.9K |
|
2284
RLX Technology
RLX
$3.18B
| $69.9K | ﹤0.01% |
37,200
-18,700
| -33% | -$35.2K |
|
2285
Orion Group Holdings
ORN
$301M
| $69K | ﹤0.01% |
+13,200
| New | +$69K |
|
2286
Ultralife
ULBI
$119M
| $68.9K | ﹤0.01% |
+12,800
| New | +$68.9K |
|
2287
SGHC Ltd
SGHC
$6.4B
| $68.3K | ﹤0.01% |
+10,600
| New | +$68.3K |
|
2288
Clover Health Investments
CLOV
$1.41B
| $67.9K | ﹤0.01% |
18,900
-5,800
| -23% | -$20.8K |
|
2289
TScan Therapeutics
TCRX
$108M
| $67.6K | ﹤0.01% |
+49,000
| New | +$67.6K |
|
2290
Health Catalyst
HCAT
$238M
| $67K | ﹤0.01% |
14,800
-14,900
| -50% | -$67.5K |
|
2291
GEN Restaurant Group
GENK
$16.3M
| $66.2K | ﹤0.01% |
12,000
-1,300
| -10% | -$7.18K |
|
|
MREO
2292
Mereo BioPharma
MREO
$282M
| $65.9K | ﹤0.01% |
+29,300
| New | +$65.9K |
|
2293
Big 5 Sporting Goods
BGFV
$32.8M
| $65.7K | ﹤0.01% |
68,000
-15,900
| -19% | -$15.4K |
|
2294
BioAtla
BCAB
$31.5M
| $65.5K | ﹤0.01% |
188,900
+127,400
| +207% | +$44.2K |
|
|
ONL
2295
Orion Office REIT
ONL
$170M
| $64.4K | ﹤0.01% |
30,100
-69,900
| -70% | -$150K |
|
2296
Real Brokerage
REAX
$1.1B
| $64.1K | ﹤0.01% |
15,800
-6,300
| -29% | -$25.6K |
|
2297
GSI Technology
GSIT
$85.2M
| $63.9K | ﹤0.01% |
31,500
+20,500
| +186% | +$41.6K |
|
|
NAK
2298
Northern Dynasty Minerals
NAK
$466M
| $63.6K | ﹤0.01% |
55,300
-85,600
| -61% | -$98.4K |
|
2299
Clear Channel Outdoor Holdings
CCO
$656M
| $63.4K | ﹤0.01% |
57,100
-63,715
| -53% | -$70.7K |
|
|
CMPS
2300
Compass Pathways
CMPS
$493M
| $62.9K | ﹤0.01% |
22,000
-19,500
| -47% | -$55.8K |
|